Back to Search
Start Over
A potential to reduce pulmonary toxicity: The use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer
- Source :
- Radiotherapy and Oncology. 83:156-162
- Publication Year :
- 2007
- Publisher :
- Elsevier BV, 2007.
-
Abstract
- Background and purpose The study aimed to examine specific avoidance of functional lung (FL) defined by a single photon emission computerized tomography (SPECT) lung perfusion scan, using intensity modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3-DCRT) in patients with non-small cell lung cancer (NSCLC). Materials and methods Patients with NSCLC underwent planning computerized tomography (CT) and lung perfusion SPECT scan in the treatment position using fiducial markers to allow co-registration in the treatment planning system. Radiotherapy (RT) volumes were delineated on the CT scan. FL was defined using co-registered SPECT images. Two inverse coplanar RT plans were generated for each patient: 4-field 3-DCRT and 5-field step-and-shoot IMRT. 3-DCRT plans were created using automated AutoPlan optimisation software, and IMRT plans were generated employing Pinnacle 3 treatment planning system (Philips Radiation Oncology Systems). All plans were prescribed to 64Gy in 32 fractions using data for the 6MV beam from an Elekta linear accelerator. The objectives for both plans were to minimize the volume of FL irradiated to 20Gy (fV 20 ) and dose variation within the planning target volume (PTV). A spinal cord dose was constrained to 46Gy. Volume of PTV receiving 90% of the prescribed dose (PTV 90 ), fV 20 , and functional mean lung dose (fMLD) were recorded. The PTV 90 /fV 20 ratio was used to account for variations in both measures, where a higher value represented a better plan. Results Thirty-four RT plans of 17 patients with stage I–IIIB NSCLC suitable for radical RT were analysed. In 6 patients with stage I–II disease there was no improvement in PTV 90 , fV 20 , PTV/fV 20 ratio and fMLD using IMRT compared to 3-DCRT. In 11 patients with stage IIIA–B disease, the PTV was equally well covered with IMRT and 3-DCRT plans, with IMRT producing better PTV 90 /fV 20 ratio (mean ratio – 7.2 vs. 5.3, respectively, p =0.001) and reduced fMLD figures compared to 3-DCRT (mean value – 11.5 vs. 14.3Gy, p =0.001). This was due to reduction in fV 20 while maintaining PTV coverage. Conclusion The use of IMRT compared to 3-DCRT improves the avoidance of FL defined by perfusion SPECT scan in selected patients with locally advanced NSCLC. If the dose to FL is shown to be the primary determinant of lung toxicity, IMRT would allow for effective dose escalation by specific avoidance of FL.
- Subjects :
- Male
medicine.medical_specialty
Lung Neoplasms
medicine.medical_treatment
Effective dose (radiation)
Carcinoma, Non-Small-Cell Lung
medicine
Humans
Radiology, Nuclear Medicine and imaging
Lung cancer
Radiation treatment planning
neoplasms
Neoplasm Staging
Tomography, Emission-Computed, Single-Photon
Lung
business.industry
Radiotherapy Planning, Computer-Assisted
Radiotherapy Dosage
Hematology
medicine.disease
Survival Rate
Radiation therapy
Treatment Outcome
medicine.anatomical_structure
Oncology
Female
Radiotherapy, Intensity-Modulated
Tomography
Radiology
Tomography, X-Ray Computed
Nuclear medicine
business
Fiducial marker
therapeutics
Perfusion
Subjects
Details
- ISSN :
- 01678140
- Volume :
- 83
- Database :
- OpenAIRE
- Journal :
- Radiotherapy and Oncology
- Accession number :
- edsair.doi.dedup.....ed355005193c6d9fff69167a9623a46b
- Full Text :
- https://doi.org/10.1016/j.radonc.2007.04.005